AAAAAA
Results: 1-25/26
Authors:
BROD SA
NELSON L
WOLINSKY JS
Citation: Sa. Brod et al., INGESTED IFN-ALPHA INDUCES MX MESSENGER-RNA IN MICE AND MAN, The FASEB journal, 12(4), 1998, pp. 3485-3485
Authors:
NELSON L
MALONE M
DARCAN S
PAPOLLA M
BROD SA
Citation: L. Nelson et al., INGESTED IFN-ALPHA SUPPRESSES IDDM IN NOD MICE, The FASEB journal, 12(4), 1998, pp. 3486-3486
Authors:
BROD SA
Citation: Sa. Brod, HYPOTHESIS - MULTIPLE-SCLEROSIS IS A TYPE-I INTERFERON DEFICIENCY SYNDROME - COMMENT, Proceedings of the Society for Experimental Biology and Medicine, 218(4), 1998, pp. 278-283
Authors:
BROD SA
MALONE M
DARCAN S
PAPOLLA M
NELSON L
Citation: Sa. Brod et al., INGESTED INTERFERON-ALPHA SUPPRESSES TYPE-I DIABETES IN NONOBESE DIABETIC MICE, Diabetologia, 41(10), 1998, pp. 1227-1232
Authors:
BROD SA
KERMAN RH
NELSON LD
MARSHALL GD
HENNINGER EM
KHAN M
JIN R
WOLINSKY JS
Citation: Sa. Brod et al., INGESTED IFN-ALPHA HAS BIOLOGICAL EFFECTS IN HUMANS WITH RELAPSING-REMITTING MULTIPLE-SCLEROSIS, Multiple sclerosis, 3(1), 1997, pp. 1-7
Authors:
KHAN M
WOLINSKY JS
NELSON LD
BROD SA
Citation: M. Khan et al., INCREASED CD4-CELL IFN-GAMMA AND CD4+ T-CELL IL-10 PRODUCTION IN RRMS( AND CD8+ T), Neurology, 48(3), 1997, pp. 1107-1107
Authors:
BROD SA
KHAN M
NELSON LD
Citation: Sa. Brod et al., ACTIVATED IFN-ALPHA FED DONOR CD8-4 TRANSFER PROTECTION AGAINST EAE(TCELLS SECRETING IL), Neurology, 48(3), 1997, pp. 15004-15004
Authors:
BROD SA
Citation: Sa. Brod, GUT RESPONSE - THERAPY WITH INGESTED IMMUNOMODULATORY PROTEINS, Archives of neurology, 54(10), 1997, pp. 1300-1302
Authors:
BROD SA
Citation: Sa. Brod, MULTIPLE-SCLEROSIS - CLINICAL PRESENTATION, DIAGNOSIS AND TREATMENT (VOL 54, PG 1301, 1996), American family physician, 55(2), 1997, pp. 448-448
Authors:
BROD SA
KHAN M
Citation: Sa. Brod et M. Khan, ORAL-ADMINISTRATION OF IFN-ALPHA IS SUPERIOR TO SUBCUTANEOUS ADMINISTRATION OF IFN-ALPHA IN THE SUPPRESSION OF CHRONIC RELAPSING EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS, Journal of autoimmunity, 9(1), 1996, pp. 11-20
Authors:
BROD SA
NELSON L
WOLINSKY JS
Citation: Sa. Brod et al., INGESTED IFN-ALPHA HAS BIOLOGICAL EFFECTS IN HUMANS, The FASEB journal, 10(6), 1996, pp. 169-169
Authors:
VRIESENDORP FJ
FLYNN RE
KHAN M
PAPPOLLA MA
BROD SA
Citation: Fj. Vriesendorp et al., ORAL-ADMINISTRATION OF TYPE-I INTERFERON MODULATES THE COURSE OF EXPERIMENTAL ALLERGIC NEURITIS, Autoimmunity, 24(3), 1996, pp. 157-165
Authors:
BROD SA
MARSHALL GD
HENNINGER EM
SRIRAM S
KHAN M
WOLINSKY JS
Citation: Sa. Brod et al., INTERFERON-BETA(1B) TREATMENT DECREASES TUMOR-NECROSIS-FACTOR-ALPHA AND INCREASES INTERLEUKIN-6 PRODUCTION IN MULTIPLE-SCLEROSIS, Neurology, 46(6), 1996, pp. 1633-1638
Authors:
BROD SA
MARSHALL GD
HENNINGER E
NELSON L
KHAN M
WOLINSKY JS
Citation: Sa. Brod et al., ORAL INTERFERON-ALPHA - BIOLOGIC EFFECTS IN NORMAL INDIVIDUALS AND SUBJECTS WITH RELAPSING-REMITTING MULTIPLE-SCLEROSIS, Neurology, 46(2), 1996, pp. 52005-52005
Authors:
BROD SA
LINDSEY JW
WOLINSKY JS
Citation: Sa. Brod et al., MULTIPLE-SCLEROSIS - CLINICAL PRESENTATION, DIAGNOSIS AND TREATMENT, American family physician, 54(4), 1996, pp. 1301
Authors:
BROD SA
SCOTT M
BURNS DK
PHILLIPS JT
Citation: Sa. Brod et al., MODIFICATION OF ACUTE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN THE LEWIS RAT BY ORAL-ADMINISTRATION OF TYPE-1 INTERFERONS, Journal of interferon & cytokine research, 15(2), 1995, pp. 115-122
Authors:
BROD SA
KHAN M
Citation: Sa. Brod et M. Khan, ORAL-ADMINISTRATION OF INTERFERON (IFN)-ALPHA IS SUPERIOR TO PARENTERAL ADMINISTRATION OF IFN-ALPHA IN THE SUPPRESSION OF CHRONIC, RELAPSING-REMITTING EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS, Annals of neurology, 38(2), 1995, pp. 341-341
Authors:
BROD SA
KHAN M
BRIGHT J
SRIRAM S
MARSHALL GJ
HENNINGER EM
KERMAN RH
WOLINSKY JS
Citation: Sa. Brod et al., DECREASED CD3-MEDIATED INTERFERON-GAMMA PRODUCTION IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS, Annals of neurology, 37(4), 1995, pp. 546-549
Authors:
BROD SA
KHAN M
KERMAN RH
PAPPOLLA M
Citation: Sa. Brod et al., ORAL-ADMINISTRATION OF HUMAN OR MURINE INTERFERON-ALPHA SUPPRESSES RELAPSES AND MODIFIES ADOPTIVE TRANSFER IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS, Journal of neuroimmunology, 58(1), 1995, pp. 61-69
Authors:
BROD SA
KHAN M
BRIGHT J
SRIRAM S
MARSHELL GD
WOLINSKY J
Citation: Sa. Brod et al., DECREASED CD3-MEDIATED INTERFERON-GAMMA PRODUCTION IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS, Neurology, 45(4), 1995, pp. 164-164
Authors:
BROD SA
SCOTT M
Citation: Sa. Brod et M. Scott, DEFECTIVE CD3 MEDIATED PROLIFERATION AND LPS RESPONSIVENESS IN MULTIPLE-SCLEROSIS, Autoimmunity, 17(2), 1994, pp. 143-148
Authors:
BROD SA
KHAN M
Citation: Sa. Brod et M. Khan, ORAL-ADMINISTRATION OF HUMAN OR MURINE TYPE-1 INTERFERONS PREVENTS RELAPSES AND ADOPTIVE TRANSFER IN EXPERIMENTAL ALLERGIC ENCEPHALITIS, Annals of neurology, 36(2), 1994, pp. 327-328
Authors:
BROD SA
BURNS DK
Citation: Sa. Brod et Dk. Burns, SUPPRESSION OF RELAPSING EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS INTHE SJL J MOUSE BY ORAL-ADMINISTRATION OF TYPE-I INTERFERONS/, Neurology, 44(6), 1994, pp. 1144-1148
Authors:
BROD SA
BURNS DK
Citation: Sa. Brod et Dk. Burns, SUPPRESSION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY ORAL-ADMINISTRATION OF TYPE-I INTERFERONS - TOLERANCE INDUCED TO MYELIN BASIC-PROTEIN IN CHRONIC RELAPSING DISEASE IN THE SJL J MOUSE/, Neurology, 43(4), 1993, pp. 410-410
Authors:
BROD SA
BURNS DK
Citation: Sa. Brod et Dk. Burns, ORAL-ADMINISTRATION OF TYPE-1 INTERFERONS PRODUCES IMMUNOLOGICAL-TOLERANCE IN CHRONIC RELAPSING EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (CR-EAE), The Journal of immunology, 150(8), 1993, pp. 173-173